Validation of broad panel clinical sequencing-based genomic risk stratification in patients with advanced lung adenocarcinomas.

被引：0
|
作者：
Whipple, Sam
Martin, Axel
Martinec, Michael
Arbour, Kathryn Cecilia
Seshan, Venkatraman E.
Riely, Gregory J.
Crane, Gracy
Shen, Ronglai
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[3] F Hoffmann La Roche Ltd, Basel, Switzerland
[4] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[5] Roche Prod Ltd, Welwyn Garden City, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9113
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Risk stratification model for patients with stage I invasive lung adenocarcinoma based on clinical and pathological predictors
    Wang, Yiyang
    Zheng, Difan
    Luo, Jizhuang
    Zhang, Jie
    Pompili, Cecilia
    Ujiie, Hideki
    Matsuura, Natsumi
    Chen, Haiquan
    Yao, Feng
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (05) : 2205 - +
  • [22] Next Generation Sequencing-Based Profiling of Cell Free DNA in Patients with Advanced Non-Small Cell Lung Cancer: Advantages and Pitfalls
    Abate, Riziero Esposito
    Frezzetti, Daniela
    Maiello, Monica Rosaria
    Gallo, Marianna
    Camerlingo, Rosa
    De Luca, Antonella
    De Cecio, Rossella
    Morabito, Alessandro
    Normanno, Nicola
    CANCERS, 2020, 12 (12) : 1 - 17
  • [23] Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy
    Zakile A. Mfumbilwa
    Martijn J. H. G. Simons
    Bram Ramaekers
    Valesca P. Retèl
    Joanne M. Mankor
    Harry J. M. Groen
    Joachim G. J. V. Aerts
    Manuela Joore
    Janneke A. Wilschut
    Veerle M. H. Coupé
    PharmacoEconomics, 2024, 42 : 419 - 434
  • [24] Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy
    Mfumbilwa, Zakile A.
    Simons, Martijn J. H. G.
    Ramaekers, Bram
    Retel, Valesca P.
    Mankor, Joanne M.
    Groen, Harry J. M.
    Aerts, Joachim G. J. V.
    Joore, Manuela
    Wilschut, Janneke A.
    Coupe, Veerle M. H.
    PHARMACOECONOMICS, 2024, 42 (04) : 419 - 434
  • [25] Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients
    Lei Zhang
    Min Luo
    Hongying Yang
    Shaoyan Zhu
    Xianliang Cheng
    Chen Qing
    Journal of Ovarian Research, 12
  • [26] Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients
    Zhang, Lei
    Luo, Min
    Yang, Hongying
    Zhu, Shaoyan
    Cheng, Xianliang
    Qing, Chen
    JOURNAL OF OVARIAN RESEARCH, 2019, 12 (1)
  • [27] The role of a sequencing-based clinical intestinal screening test in patients at high-risk for Clostridium difficile and other pathogens: a case report
    Maureen Hitschfeld
    Elena Tovar
    Sarah Gupta
    Elisabeth M. Bik
    Christina Palmer
    Michael C. Hoaglin
    Daniel E. Almonacid
    Jessica Richman
    Zachary S. Apte
    Journal of Medical Case Reports, 13
  • [28] The role of a sequencing-based clinical intestinal screening test in patients at high-risk for Clostridium difficile and other pathogens: a case report
    Hitschfeld, Maureen
    Tovar, Elena
    Gupta, Sarah
    Bik, Elisabeth M.
    Palmer, Christina
    Hoaglin, Michael C.
    Almonacid, Daniel E.
    Richman, Jessica
    Apte, Zachary S.
    JOURNAL OF MEDICAL CASE REPORTS, 2019, 13 (01)
  • [29] Clinical validation of the next-generation sequencing-based Extended RAS Panel assay using metastatic colorectal cancer patient samples from the phase 3 PRIME study
    Nitin Udar
    Catherine Lofton-Day
    Jun Dong
    Darcy Vavrek
    A. Scott Jung
    Kristen Meier
    Anita Iyer
    Ryan Slaughter
    Karen Gutekunst
    Bruce A. Bach
    Marc Peeters
    Jean-Yves Douillard
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 2001 - 2010
  • [30] Clinical validation of the next-generation sequencing-based Extended RAS Panel assay using metastatic colorectal cancer patient samples from the phase 3 PRIME study
    Udar, Nitin
    Lofton-Day, Catherine
    Dong, Jun
    Vavrek, Darcy
    Jung, A. Scott
    Meier, Kristen
    Iyer, Anita
    Slaughter, Ryan
    Gutekunst, Karen
    Bach, Bruce A.
    Peeters, Marc
    Douillard, Jean-Yves
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (10) : 2001 - 2010
12345